Availability and choice of antimalarials at medicine outlets in Ghana: The question of access to effective medicines for malaria control

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 5, 2008, Pages 613-619

  Buabeng, K O ^a,b   Duwiejua, M ^b   Matowe, L K ^c   Smith, F ^d   Enlund, H ^a,e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c Center for Pharmaceutical Management   (United States)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CRYPTOLEPINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; QUININE;

ARTICLE; CLINICAL PRACTICE; GHANA; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HOSPITAL PHARMACY; MALARIA; MALARIA CONTROL; OUTPATIENT DEPARTMENT; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTIMALARIALS; CHILD, PRESCHOOL; FEMALE; GHANA; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; MALARIA; PHARMACIES; PHARMACY SERVICE, HOSPITAL; PREGNANCY;

EID: 54249165378     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.130     Document Type: Article

References (24)

1. Koram, K.A., Abuaku, B., Duah, N. & Quarshie, N. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 95, 194-203 (2005).
2. Guerin, P.J. et al. Malaria: current status of control, diagnosis, treatment and a proposed agenda for research and development. Lancet Infect. Dis. 2, 565-571 (2007).
3. Agyepong, I.A. & Kangeya-Kayonda, J. Providing practical estimates of malaria burden for health planners in resource-poor countries. Am. J. Trop. Med. Hyg. 71, 162-167 (2004).
4. Banda, J.J. et al. Ghana roll back malaria consultative mission (reaping): essential actions to support the attainment of the Abuja targets, 26-30 January 2003 〈http://www.rollbackmalaria.org/partnership/country/ docs/WAfrica/reaping_ghana.pdf〉 (2004). Accessed August 2007.
5. World Health Organization: progress report on implementation of the plan of action of the Abuja declaration 2004 〈http://www.afro.who.int/malaria/ publications/cover_toc.pdf〉 Banda, J.J. et al. Ghana roll back malaria consultative mission (reaping): essential actions to support the attainment of the Abuja targets, 26-30 January 2003 〈http://www. rollbackmalaria.org/partnership/country/docs/WAfrica/reaping_ghana.pdf〉 (2004). Accessed September 2007.
6. World Health Organization: African summit on Roll Back Malaria 2000 〈http://www.rollbackmalaria.org/docs/abuja_declaration.pdf〉 (2003). Accessed December 2005.
7. Nyunt, M.M. & Plowe, C.V. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin. Pharmacol. Ther. 82, 601-604 (2007).
8. Ofori-Adjei, D. David Ofori-Adjei - building bridges for health care and research in Ghana. Interviewed by Julia Royall. Lancet Infect. Dis. 3, 251-254 (2003).
9. Ahorlu, C.K., Dunyo, S.K., Afari, E.A., Koram, K.A. & Nkrumah, F.K. Malaria-related beliefs and behaviour in Southern Ghana: implications for treatment, prevention and control. Trop. Med. Int. Health 2, 488-499 (1997).
10. Amin, A.A. & Snow, W.R. Brands, cost and registration status of antimalarial drugs in the Kenyan retail sector. Malar. J. 4, 36 (2005).
11. Barnes, K.I. et al. World Antimalarial Resistance Network (WARN) IV: clinical Pharmacology. Malar. J. 6, 122 (2007).
12. Willcox, M.L. & Bodeker, G. Critical review: traditional herbal medicines for malaria. BMJ 329, 1156-1159 (2004).
13. Lang, T. et al. Beyond registration-measuring the public-health potential of new treatments for malaria in Africa. Lancet Infect. Dis. 6, 46-52 (2006).
14. Kazembe, N.L., Appleton, C.C. & Kleinshmidt, I. Choice of treatment for fever at household level in Malawi: examining spatial patterns. Malar. J. 6, 40 (2007).
15. Buabeng, K.O., Duwiejua, M., Dodoo, A.N.O., Matowe, L. & Enlund, H. Self-reported use of anti-malarial drugs and health facility management of malaria in Ghana. Malar. J. 6, 85 (2007).
16. Davis, T.M.E., Karunajeewa, H.A. & Ilett, K.F. Artemisinin-based combination therapies for umcomplicated malaria. Med. J. Aust. 182, 181-185 (2005).
17. Dzator, J. & Asafu-Adjaye, J. A study of malaria care provider choice in Ghana. Health Policy 69, 389-401 (2004).
18. Robertson, J. & Hill, S.R. The essential medicines list for a global patient population. Clin. Pharmacol. Ther. 82, 498-450 (2007).
19. Kaona, F.A.D. & Tuba, M. A qualitative study to identify community structures for management of severe malaria: a basis for introducing rectal artesunate in the under five years children in Nakonde District of Zambia. BMC Public Health 5, 28 (2005).
20. Afenyadu, G.Y., Agyepong, I.A., Barnish, G. & Adjei, S. Improving access to early treatment of malaria: a trial with primary school teachers as care providers. Trop. Med. Int. Health 10, 1065-1072 (2005).
21. Nsabagasani, X., Jesca-Nsungwa-Sabiiti, Källander, K., Peterson, S., Pariyo, G., Tomson, G. Home-based management of fever in rural Uganda: community perceptions and provider opinions. Malar. J. 6, 11 (2007).
22. Cohen-Kohler, J.C. The morally uncomfortable global drug gap. Clin. Pharmacol. Ther. 82, 610-614 (2007).
23. Drager, S., Gedik, G., Dal Poz, M.R. Health workforce issues and the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analytical review. Hum. Resour. Health 4, 23 (2006).
24. ILO: The Global Social Trust: Health Insurance in Ghana 2005 〈http://www.ilo.org/global/About_the_ILO/media_and_public_information/ 〉 (2005). Accessed 20 March 2008.